Dianthus Therapeutics, Inc. - DNTH
About Gravity Analytica
Recent News
- 09.16.2025 - Bill Maughan, Ph.D.
- 09.16.2025 - Bill Maughan, Ph.D.
- 09.11.2025 - Dianthus Therapeutics, Inc. Announces Closing of its Upsized $288 Million Underwritten Public Offering Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
- 09.11.2025 - Dianthus Therapeutics, Inc. Announces Closing of its Upsized $288 Million Underwritten Public Offering Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
- 09.10.2025 - Dianthus Therapeutics, Inc. Announces Pricing of Upsized $251 Million Underwritten Public Offering
- 09.10.2025 - Dianthus Therapeutics, Inc. Announces Pricing of Upsized $251 Million Underwritten Public Offering
- 09.08.2025 - Dianthus Therapeutics, Inc. Announces Proposed $150 Million Underwritten Public Offering
- 09.08.2025 - Dianthus Therapeutics, Inc. Announces Proposed $150 Million Underwritten Public Offering
- 09.08.2025 - Dianthus Therapeutics Ph. 2 MaGic Data Investor Webcast
- 09.08.2025 - Dianthus Therapeutics Ph. 2 MaGic Data Investor Webcast
Recent Filings
- 09.15.2025 - SCHEDULE 13D/A General Statement of Acquisition of Beneficial Ownership
- 09.12.2025 - SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors
- 09.11.2025 - 4 Statement of changes in beneficial ownership of securities
- 09.11.2025 - 8-K Current report
- 09.11.2025 - 424B5 Prospectus [Rule 424(b)(5)]
- 09.09.2025 - 144 Report of proposed sale of securities
- 09.08.2025 - EX-99.1 EX-99.1
- 09.08.2025 - 8-K Current report